Placenta expressed proteins for use in the treatment of tendon injury
AssigneeUniversity College Cork, National University of Ireland, Cork
InventorTom Moore
Life of this patent
Estimating the term…
Abstract
The use of Fc-tagged Pregnancy-specific glycoprotein 1 (PSG1-Fc) in a method of treatment of a tendon injury in a human, in which the PSG1 is administered by intra-tendon or peri-tendon injection, is described. Also described is the use of CC49 in a method of treatment of tendonitis, tendinosis, tendinopathy, or tendon damage in an equine mammal, in which the CC49 is administered by intra-tendon or peri-tendon injection.
Claims12
A method of treatment of a tendon injury in a human, comprising administering a therapeutically effective amount of pregnancy specific glycoprotein 1 (PSG1) to the human by intra-tendon or peri-tendon injection.
A method of treatment of a tendon injury in an equine mammal, comprising administering to the equine mammal a therapeutically effective amount of CC49 by intra-tendon or peri-tendon injection.
A method according to claim Z, in which the method includes administering mesenchymal stem cells to the injured tendon by intra-tendon or peri-tendon injection.
Dependencies are inferred from the claim text.